Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Cardiology

Clinical Pharmacology

Role of chronic continuous intravenous lidocaine in the clinical management of patients with malignant type 3 long QT syndrome

Heart Rhythm | Oct 14, 2021 Clinical Pharmacology

Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trial

Diabetes, Obesity and Metabolism | Oct 14, 2021 Clinical Pharmacology

Kidney transplant list status and outcomes in the ISCHEMIA-CKD trial

Journal of the American College of Cardiology | Oct 14, 2021 Clinical Pharmacology

Side effect patterns in a crossover trial of statin, placebo, and no treatment

Journal of the American College of Cardiology | Oct 14, 2021 Clinical Pharmacology

Trial of intensive blood-pressure control in older patients with hypertension

New England Journal of Medicine | Oct 13, 2021 Clinical Pharmacology

Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): An investigator-initiated, open-label, multicentre, non-inferiority, randomised trial

The Lancet | Oct 13, 2021 Clinical Pharmacology

Sacubitril/valsartan initiation among veterans who are renin‐angiotensin‐aldosterone system inhibitor naïve with heart failure and reduced ejection fraction

Journal of the American Heart Association | Oct 13, 2021 Clinical Pharmacology

Optimal uric acid levels by febuxostat treatment and cerebral, cardiorenovascular risks: Post hoc analysis of a randomised controlled trial

Rheumatology | Oct 12, 2021 Clinical Pharmacology

Determinants of the survival benefit associated with statins in patients with acute heart failure

ESC Heart Failure | Oct 11, 2021 Clinical Pharmacology

Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death

Cardiovascular Diabetology | Oct 10, 2021 Clinical Pharmacology

« Prev 1 … 10 11 12 13 14 … 163 Next »

Role of chronic continuous intravenous lidocaine in the clinical management of patients with malignant type 3 long QT syndrome

Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trial

Kidney transplant list status and outcomes in the ISCHEMIA-CKD trial

Side effect patterns in a crossover trial of statin, placebo, and no treatment

Trial of intensive blood-pressure control in older patients with hypertension

Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): An investigator-initiated, open-label, multicentre, non-inferiority, randomised trial

Sacubitril/valsartan initiation among veterans who are renin‐angiotensin‐aldosterone system inhibitor naïve with heart failure and reduced ejection fraction

Optimal uric acid levels by febuxostat treatment and cerebral, cardiorenovascular risks: Post hoc analysis of a randomised controlled trial

Determinants of the survival benefit associated with statins in patients with acute heart failure

Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Article on Strategies to Reduce Antibiotic Misuse and Address Antimicrobial Resistance

The 1 food geriatricians avoid to live a long, healthy life

Many young adults have high long-term risk for cardiovascular disease, study finds

Role of chronic continuous intravenous lidocaine in the clinical management of patients with malignant type 3 long QT syndrome

Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trial

Kidney transplant list status and outcomes in the ISCHEMIA-CKD trial

Side effect patterns in a crossover trial of statin, placebo, and no treatment

Trial of intensive blood-pressure control in older patients with hypertension

Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): An investigator-initiated, open-label, multicentre, non-inferiority, randomised trial

Sacubitril/valsartan initiation among veterans who are renin‐angiotensin‐aldosterone system inhibitor naïve with heart failure and reduced ejection fraction

Optimal uric acid levels by febuxostat treatment and cerebral, cardiorenovascular risks: Post hoc analysis of a randomised controlled trial

Determinants of the survival benefit associated with statins in patients with acute heart failure

Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Article on Strategies to Reduce Antibiotic Misuse and Address Antimicrobial Resistance

The 1 food geriatricians avoid to live a long, healthy life

Many young adults have high long-term risk for cardiovascular disease, study finds

Select Specialty

Select Topic